A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1196
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : rhGH
Long Form : recombinant human growth hormone
No. Year Title Co-occurring Abbreviation
2022 A meta-analysis of combination therapy with gonadotrophin-releasing hormone agonist and growth hormone for children with idiopathic short stature and normal timed puberty. FH-PAH, FH-TH, FHSDS, GnRHa, ISS
2022 A proof-of-concept study of growth hormone in children with Phelan-McDermid syndrome. ASD, IGF-1, PMS
2022 A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency. BA, CA, GHD, HtSDS, IGF-1, ISS
2022 Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study. ---
2022 Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care. GH, HCPs
2022 Association Between Recombinant Growth Hormone Therapy and All-Cause Mortality and Cancer Risk in Childhood: Systematic Review and Meta-Analysis. RR, SIR, SMRs
2022 Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH. ACMG, NGS
2022 Counseling for Growth Hormone Therapy. GH, GHD
2022 Differentially methylated CpGs in response to growth hormone administration in children with idiopathic short stature. DMCs, ISS
10  2022 Early corticosteroid withdrawal is associated with improved adult height in pediatric kidney transplant recipients. FH
11  2022 Effects of high-dose recombinant human growth hormone treatment on IGF-1 and IGFBP-3 levels in idiopathic dwarfism patients. IGF-1, IGFBP-3
12  2022 Efficacy and safety of recombinant human growth hormone therapy in pediatric intestinal transplant recipients. IT
13  2022 Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. GHD, HV
14  2022 Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants. FSS, Tianjin, China
15  2022 Factors influencing height gain in children born small for gestational age treated with recombinant growth hormone: what extent is puberty involved? SGA
16  2022 Growth Hormone Increases BDNF and mTOR Expression in Specific Brain Regions after Photothrombotic Stroke in Mice. BDNF, GH, mTOR
17  2022 Growth Hormone Is Beneficial for Induction of Spermatogenesis in Adult Patients With Congenital Combined Pituitary Hormone Deficiency. CCPHD
18  2022 Growth hormone therapy in HHRH. HHRH
19  2022 Increased testicular insulin-like growth factor 1 is associated with gonadal activation by recombinant growth hormone in immature rats. IGF1, PND
20  2022 Investigating the Impact of the TUITEK® Patient Support Programme, Designed to Support Caregivers of Children Prescribed Recombinant Human Growth Hormone Treatment in Taiwan. ---
21  2022 Long-acting growth hormone preparations and their use in children with growth hormone deficiency. GHD, LAGH
22  2022 Metabolic Effects of Recombinant Human Growth Hormone Replacement Therapy on Juvenile Patients after Craniopharyngioma Resection. AST, BMI, CP, FBG, GHRT, hs-CRP, LDL, SCr, TC
23  2022 Molecular Classes and Growth Hormone Treatment Effects on Behavior and Emotion in Patients with Prader-Willi Syndrome. BASC-2, del, PWS, RDCRN
24  2022 Novel Loss-of-Function Mutations in NPR2 Cause Acromesomelic Dysplasia, Maroteaux Type. AMDM, NPR2
25  2022 Observed High Adherence to Recombinant Human Growth Hormone Treatment Using a Multi-Component Approach to Improve Adherence in Individuals with Growth Disorders. PAM, PSP
26  2022 One Year of Recombinant Human Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition, Motor Skills and Brain Functional Activity in the Cerebellum. BBS, TUG
27  2022 Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device. PSP
28  2022 Response to Treatment with Recombinant Human Growth Hormone (rhGH) of Short Stature Children Born Too Small for Gestational Age (SGA) in Selected Centres in Poland. DYSM, FAS, SGA, SRS
29  2022 Role of ZBTB38 Genotype and Expression in Growth and Response to Recombinant Human Growth Hormone Treatment. ISS, SNPs
30  2022 Safety and effectiveness of Omnitrope® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data. GHD, PATRO
31  2022 Should Skeletal Maturation Be Manipulated for Extra Height Gain? AH, AI, GnRHa
32  2022 Thyroid function in children with Prader-Willi syndrome in Southern China: a single-center retrospective case series. C-HT, FT4, PWS, TSH
33  2022 Transdermal Co-Delivery of Urea and Recombinant Human Growth Hormone. HP-beta-CD
34  2022 Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review. GHD
35  2022 Treatment of congenital adrenal hyperplasia and Klinefelter Syndrome with central precocious puberty: a case report. CAH, CPP, GnRHa, HPG, KS
36  2022 Treatment of Isolated Idiopathic Growth Hormone Deficiency in Children and Thyroid Function: Is the Need for LT4 Supplementation a Concern in Long-Term Therapy? GHD, GV, IGF-1, PAH, SDS, TSH
37  2022 Two Japanese patients with Noonan syndrome-like disorder with loose anagen hair 2. NSLH, PP1
38  2022 Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device. ---
39  2022 Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study. ECOS, SDS
40  2021 A case report of Phelan-McDermid syndrome: preliminary results of the treatment with growth hormone therapy. CNV, IGF-1, PMS
41  2021 A Data-Driven Intervention Framework for Improving Adherence to Growth Hormone Therapy Based on Clustering Analysis and Traffic Light Alerting Systems. AUC-ROC, GHD, SD
42  2021 A rare case of 46, XX (SRY positive) testicular disorder of sex development with growth hormone deficiency: Case report. DSD, GH, GHD, PCR, SDS
43  2021 A Retrospective Analysis of Patients with Short Stature in Eastern China between 2013 and 2019. SDS
44  2021 Adult height after treatment of neurosecretory dysfunction and comparison to idiopathic GHD. GHD, NSD, SDS
45  2021 Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature. GV, Ht, HtSDS, IGF-1, ISS
46  2021 Approach to the Patient: Safety of Growth Hormone Replacement in Children and Adolescents. GHD
47  2021 Aromatase Inhibitor Increases the Height of Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. 21OHD, AI, GnRH
48  2021 Association of thyroid autoimmunity and the response to recombinant human growth hormone in Turner syndrome. HV, TS
49  2021 Case Report: A Clinical and Genetic Analysis of Childhood Growth Hormone Deficiency With Familial Hypercholesterolemia. apoB, FH, GH, GHD, LDL-C, LDLR
50  2021 Case Report: Homozygous DNAJC3 Mutation Causes Monogenic Diabetes Mellitus Associated With Pancreatic Atrophy. GH, MRI, WES
51  2021 Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review. GHD, IGF-1, SDS
52  2021 Clinical features, genetic detection and therapeutic response to rhGH of children with Noonan syndrome: an analysis of 12 cases. IGF-1, NS
53  2021 Comparison of Frequency and Severity of Sleep-Related Breathing Disorders in Children with Simple Obesity and Paediatric Patients with Prader-Willi Syndrome. AHI, AI, HI, HOMA-IR, ODI, OGTT, PSG, PWS, SRBDs
54  2021 Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome. BMI, IGF1, PWS
55  2021 Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD. GHD, GHS, HV, IGF-I, SDS
56  2021 Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency. ---
57  2021 Determinants of Final Height in Patients Born Small for Gestational Age Treated with Recombinant Growth Hormone. GnRH, SGA
58  2021 Effects of Recombinant Human Growth Hormone on the Onset of Puberty, Leydig Cell Differentiation, Spermatogenesis and Hypothalamic KISS1 Expression in Immature Male Rats. PND
59  2021 Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader-Willi Syndrome: A Polish Multicentre Study. BA/CA, BMI, GV, IGF1, PWS
60  2021 Efficacy of Growth Hormone Treatment in Children with Chronic Kidney Disease: Tunisian Experience. CKD
61  2021 Efficacy of Growth Hormone Treatment in Children With Chronic Kidney Disease: Tunisian Experience. CKD
62  2021 Etiology and Treatment of Growth Delay in Noonan Syndrome. GH, IGF-1
63  2021 Floating-Harbor Syndrome Treated With Recombinant Human Growth Hormone: A Case Report and Literature Review. FHS
64  2021 Gene expression signatures predict response to therapy with growth hormone. GHD, TS
65  2021 Genetic Screening for Growth Hormone Therapy in Children Small for Gestational Age: So Much to Consider, Still Much to Discover. SGA
66  2021 GH Deficiency and Replacement Therapy in Hypopituitarism: Insight Into the Relationships With Other Hypothalamic-Pituitary Axes. GHD, MPHD
67  2021 Growth hormone treatment in the pre-transplant period is associated with superior outcome after pediatric kidney transplantation. CKD, CRP, KT
68  2021 Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment. BMI, GH, GHD, GHD, HtSDS, IGFISDS, ISS, WGPD
69  2021 Highly efficient porous magnetic polydopamine/copper phosphate with three-dimensional hierarchical nanoflower morphology as a selective platform for recombinant proteins separation. ---
70  2021 Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database. IGF-I, IGFBP-3, IGHD, SDS
71  2021 Lipoatrophy associated with daily growth hormone injections. GH
72  2021 Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age. AEs, SGA
73  2021 Microdeletion in the IGF-1 receptor gene of a patient with short stature and obesity: a case report. Igf1r, IGHD
74  2021 NPR2 gene variants in familial short stature: a single-center study. FSS, ISS, LWD, SD, trio-WES
75  2021 One-year follow-up of thyroid function in 23 infants with Prader- Willi syndrome at a single center in China. PWS, TSH, UPD
76  2021 Patient preferences for growth hormone treatment in Japanese children. DCE, GHD
77  2021 PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope (somatropin) treatment in children: update on the United States cohort. GHD, ISS, US
78  2021 Pharmacogenomics applied to recombinant human growth hormone responses in children with short stature. ---
79  2021 Preliminary study of longitudinal changes in the pituitary and brain of children on growth hormone therapy. IGHD
80  2021 Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment. SGA
81  2021 Recombinant growth hormone therapy for cystic fibrosis in children and young adults. CF, ICTRP
82  2021 Recombinant Human Growth Hormone Activates Neuroprotective Growth Factors in Hypoxic Brain Injury in Neonatal Mice. BBB, EPO, VEGFA
83  2021 Recombinant Human Growth Hormone Inhibits Lipotoxicity, Oxidative Stress, and Apoptosis in a Mouse Model of Diabetic Cardiomyopathy. ---
84  2021 Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. AEs, GHD, HtSDSCA, PEG-rhGH
85  2021 Sexual Dysfunction: A Neglected and Overlooked Issue in Adult GH Deficiency: The Management of AGHD Study. AGHD, EF, FSFI, IIEF-15, QLS-H, QoL, QoL-AGHDA, SD
86  2021 Testicular Growth and Pubertal Onset in GH-Deficient Children Treated With Growth Hormone: A Retrospective Study. GHD, IGF1, TV
87  2021 The Auxological and Metabolic Consequences for Children Born Small for Gestational Age. SD
88  2021 The effects of growth hormones on the growth velocities and serum index expressions in short stature children. BAP, BMI, FINS, GV, HDL, HOMA-IR, IGF-1, LDL, TC, TG, TSH
89  2021 The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency. FDA, GH, GHD, TSH
90  2021 The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review. WES
91  2021 Thyroid Hormone Changes Related to Growth Hormone Therapy in Growth Hormone Deficient Patients. GHD, HPT, L-thyroxine
92  2021 To increase body height and muscle strength - one medicine for two diseases? Case report of a boy with Silver-Russell syndrome and Duchenne muscular dystrophy. DMD, SRS
93  2021 Treatment of Growth Hormone Deficiency via Daily Intravascular Injections in a Child with Bleeding Disorder. GHD, IGF1
94  2021 Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human Growth Hormone: 1-Year Response. ACAN, BA, HtSDS, HV
95  2020 A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet. GHD, GLUT1DS
96  2020 A case report of Noonan syndrome-like disorder with loose anagen hair 2 treated with recombinant human growth hormone. GH, NSLH2, PPP1CB
97  2020 A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I). rhIGF-I
98  2020 Analysis of real-world data on growth hormone therapy adherence using a connected injection device. ADSS
99  2020 Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity. GHD, HR, ISS, SGA
100  2020 Cleidocranial dysplasia with growth hormone deficiency: a case report. CCD, GHD